Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North America, 1st Edition
Author :
Edited by Alexander Fanaroff, MD, MHS and John W. Hirshfeld Jr, MD
In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insigh
...view more
In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease.
In this issue of Medical Clinics of North America, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of Patient Management with Stable Ischemic Heart Disease. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease.
Key Features
Contains 13 relevant, practice-oriented topics including optimal medical therapy for stable ischemic heart disease in 2024: focus on antithrombotic therapy; antiplatelet therapy for patients that have undergone revascularization within the past year: which agents and for how long; ischemic heart disease in women: focus on SCAD and MINOCA; and more.
Provides in-depth clinical reviews on patient management with stable ischemic heart disease, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Alexander Fanaroff, MD, MHS, Assistant Professor of Medicine, University of Pennsylvania, Perelman School of Medicine, Cardiac Catheterization Laboratory, Pavilion Hospital of the University of Pennsylvania, Philadelphia, PA, USA and John W. Hirshfeld Jr, MD, Emeritus Professor CE of Medicine Staff Cardiologist, Philadelphia VA, Medical Center Cardiac Catheterization Laboratory, Pavilion Hospital of the University of Pennsylvania, Philadelphia, PA, USA
Edited by Alexander Fanaroff, MD, MHS, Assistant Professor of Medicine, University of Pennsylvania, Perelman School of Medicine, Cardiac Catheterization Laboratory, Pavilion Hospital of the University of Pennsylvania, Philadelphia, PA, USA and John W. Hirshfeld Jr, MD, Emeritus Professor CE of Medicine Staff Cardiologist, Philadelphia VA, Medical Center Cardiac Catheterization Laboratory, Pavilion Hospital of the University of Pennsylvania, Philadelphia, PA, USA
The Pathophysiologic Basis of Managing Chronic Atherosclerotic Cardiovascular Disease Diagnosing Coronary Artery Disease in the Patient Presenting with Stable Ischemic Heart Disease: The Role of Anatomic versus Functional Testing Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Blood Pressure and Lipids Optimal Medical Therapy for Stable Ischemic Heart Disease: Focus on Anti-anginal Therapy A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart Disease Among Patients with Diabetes and/or Obesity Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Exercise and Cardiac Rehabilitation When to Consider Coronary Revascularization for Stable Coronary Artery Disease Antiplatelet Therapy for Patients Who Have Undergone Revascularization Within the Past Year: Which Agents and for How Long? Medical Decision-Making and Revascularization in Ischemic Cardiomyopathy Ischemic Heart Disease in Women Chronic Coronary Disease in Older Adults Racial and Ethnic Disparities in the Management of Chronic Coronary Disease
https://www.asia.elsevierhealth.com/patient-management-with-stable-ischemic-heart-disease-an-issue-of-medical-clinics-of-north-america-9780443293689.html311079Patient Management with Stable Ischemic Heart Disease, An Issue of Medical Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780443293689_7.jpg66.7488.99USDInStock/Medicine/Clinical/General Medicine/Medicine/Clinical/General Medicine/Clinics/Clinics/Japan Titles/Medicine & Surgery/Clinical/General Medicine/Clinics505459152598745054666525504152631604335102438872514886536505455351451205259833525987341826924335088In this issue of <i>Medical Clinics of North America</i>, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of <b>Patient Management with Stable Ischemic Heart Disease</b>. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease. In this issue of <i>Medical Clinics of North America</i>, guest editors Drs. Alexander Fanaroff and John W. Hirschfeld, Jr., bring their considerable expertise to the topic of <b>Patient Management with Stable Ischemic Heart Disease</b>. Top experts provide insights into newer diagnostic modalities for patients presenting with symptoms of stable ischemic heart disease, review the pillars of medical management as well as emerging cardiometabolic therapies, provide updates on the role of revascularization, and reveal gender, racial, ethnic, and socioeconomic disparities in the presentation and management of stable ischemic heart disease.00add-to-cart97804432936892024ProfessionalEdited by Alexander Fanaroff, MD, MHS and John W. Hirshfeld Jr, MD20241Book152w x 229h (6.00" x 9.00")Elsevier240Apr 2, 2024IN STOCKEdited by <STRONG>Alexander Fanaroff</STRONG>, MD, MHS, Assistant Professor of Medicine, University of Pennsylvania, Perelman School of Medicine, Cardiac Catheterization Laboratory, Pavilion Hospital of the University of Pennsylvania, Philadelphia, PA, USA and <STRONG>John W. Hirshfeld Jr</STRONG>, MD, Emeritus Professor CE of Medicine Staff Cardiologist, Philadelphia VA, Medical Center Cardiac Catheterization Laboratory, Pavilion Hospital of the University of Pennsylvania, Philadelphia, PA, USAClinicsClinicsThe Clinics: Internal MedicineUnited StatesYesYesNoNoPlease SelectPlease SelectPlease Select
